COMMENTARY: BRCA1/2 Mutations, Vulnerability to Breast/Ovarian Cancer, and Current and Future Treatment Modalities. Journal of Cancer Research Updates, [S. l.], v. 5, n. 2, p.  45–46, 2016. DOI: 10.6000/1929-2279.2016.05.02.1. Disponível em: https://mail.neoplasiaresearch.com/index.php/jcru/article/view/435. Acesso em: 25 may. 2026.